Review
doi: 10.1136/dtb.2004.421289.What's wrong with prescribing hypnotics?
No authors listed
- PMID:15587763
- DOI: 10.1136/dtb.2004.421289
Item in Clipboard
Review
What's wrong with prescribing hypnotics?
No authors listed. Drug Ther Bull.2004 Dec.
Display options
Format
Display options
Format
Abstract
Expert bodies have long advised that use of hypnotic drugs should be limited to short courses for acutely distressed patients and should generally be avoided in elderly people. Despite this, more than 10 million prescriptions for hypnotics continue to be dispensed each year in England alone, mostly for benzodiazepines and drugs with similar actions such as zaleplon, zolpidem and zopiclone (so called 'Z-drugs'). Around 80% of all such prescriptions are for people aged 65 years or over, and many patients remain on the drugs for months or years. Such prescribing carries many potential hazards for patients, including risk of dependence, accidents and other adverse effects on health. Here we review how the risks from hypnotic drugs can be minimised.
Similar articles
- Hypnotic dependence: zolpidem and zopiclone too.[No authors listed][No authors listed]Prescrire Int. 2001 Feb;10(51):15.Prescrire Int. 2001.PMID:11503851
- Medicines associated with dependence or withdrawal: a mixed-methods public health review and national database study in England.Marsden J, White M, Annand F, Burkinshaw P, Carville S, Eastwood B, Kelleher M, Knight J, O'Connor R, Tran A, Willey P, Greaves F, Taylor S.Marsden J, et al.Lancet Psychiatry. 2019 Nov;6(11):935-950. doi: 10.1016/S2215-0366(19)30331-1. Epub 2019 Oct 3.Lancet Psychiatry. 2019.PMID:31588045Free PMC article.Review.
- Long-term benzodiazepine and Z-drugs use in England: a survey of general practice [corrected].Davies J, Rae TC, Montagu L.Davies J, et al.Br J Gen Pract. 2017 Sep;67(662):e609-e613. doi: 10.3399/bjgp17X691865. Epub 2017 Jul 17.Br J Gen Pract. 2017.PMID:28716996Free PMC article.
- Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation.Dündar Y, Boland A, Strobl J, Dodd S, Haycox A, Bagust A, Bogg J, Dickson R, Walley T.Dündar Y, et al.Health Technol Assess. 2004 Jun;8(24):iii-x, 1-125. doi: 10.3310/hta8240.Health Technol Assess. 2004.PMID:15193209Review.
- Sleep complaints: Whenever possible, avoid the use of sleeping pills.[No authors listed][No authors listed]Prescrire Int. 2008 Oct;17(97):206-12.Prescrire Int. 2008.PMID:19536941
Cited by
- Oral Delivered Dexmedetomidine Promotes and Consolidates Non-rapid Eye Movement Sleep via Sleep-Wake Regulation Systems in Mice.Feng ZX, Dong H, Qu WM, Zhang W.Feng ZX, et al.Front Pharmacol. 2018 Dec 5;9:1196. doi: 10.3389/fphar.2018.01196. eCollection 2018.Front Pharmacol. 2018.PMID:30568589Free PMC article.
- Antidepressants for the treatment of insomnia : a suitable approach?Wiegand MH.Wiegand MH.Drugs. 2008;68(17):2411-7. doi: 10.2165/0003495-200868170-00001.Drugs. 2008.PMID:19016570
- Clinical diagnosis and misdiagnosis of sleep disorders.Stores G.Stores G.J Neurol Neurosurg Psychiatry. 2007 Dec;78(12):1293-7. doi: 10.1136/jnnp.2006.111179.J Neurol Neurosurg Psychiatry. 2007.PMID:18024690Free PMC article.Review.
- Magic bullets for insomnia? Patients' use and experiences of newer (Z drugs) versus older (benzodiazepine) hypnotics for sleep problems in primary care.Siriwardena AN, Qureshi MZ, Dyas JV, Middleton H, Orner R.Siriwardena AN, et al.Br J Gen Pract. 2008 Jun;58(551):417-22. doi: 10.3399/bjgp08X299290.Br J Gen Pract. 2008.PMID:18505619Free PMC article.
- Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review.Pollmann AS, Murphy AL, Bergman JC, Gardner DM.Pollmann AS, et al.BMC Pharmacol Toxicol. 2015 Jul 4;16:19. doi: 10.1186/s40360-015-0019-8.BMC Pharmacol Toxicol. 2015.PMID:26141716Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical